Alcalde-Estévez, E., Arroba, A. I., Sánchez-Fernández, E. M., Ortiz-Mellet, C., García Fernández, J. M., Masgrau, L., & Valverde, Á. M. (2018). The sp2-iminosugar glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) as selective anti-inflammatory agent by modulation of hemeoxygenase-1 in Bv.2 microglial cells and retinal explants.
Citación estilo ChicagoAlcalde-Estévez, Elena, Ana I. Arroba, Elena M. Sánchez-Fernández, Carmen Ortiz-Mellet, José Manuel García Fernández, Laura Masgrau, y Ángela M. Valverde. The Sp2-iminosugar Glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) As Selective Anti-inflammatory Agent By Modulation of Hemeoxygenase-1 in Bv.2 Microglial Cells and Retinal Explants. 2018.
Cita MLAAlcalde-Estévez, Elena, et al. The Sp2-iminosugar Glycolipid 1-dodecylsulfonyl-5N,6O-oxomethylidenenojirimycin (DSO2-ONJ) As Selective Anti-inflammatory Agent By Modulation of Hemeoxygenase-1 in Bv.2 Microglial Cells and Retinal Explants. 2018.